Hemangioblastoma

7 registered clinical trials studyying Hemangioblastoma — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Agnostic Therapy in Rare Solid Tumors NCT06638931	Instituto do Cancer do Estado de São Paulo	Phase 2
Recruiting	Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-N NCT05259605	European Organisation for Research and Treatment of Cancer - EORTC	—
Recruiting	68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. NCT04081701	Weill Medical College of Cornell University	Phase 4
Completed	Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease NCT00970970	University Medical Center Groningen	—
Completed	Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma NCT00589784	Memorial Sloan Kettering Cancer Center	Phase 2
Terminated	Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follo NCT00330564	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease NCT00005902	National Institute of Neurological Disorders and Stroke (NINDS)	—